Recursion Pharmaceuticals-a(RXRX)
$6.38▲8.32%
Market is closed - opens 8 PM, 29 Nov 2024
Insights
- Recursion Pharmaceuticals-a is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Recursion Pharmaceuticals-a stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Recursion Pharmaceuticals-a stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Recursion Pharmaceuticals-a stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 48.83 | Neutral |
Stochastic | 26.99, 16.96 | Neutral |
Ultimate Oscillator | 48.09 | Neutral |
Stochastic Relative Strength Index | 22.92, 12.92 | Neutral |
Moving Average Convergence Divergence | -0.19, -0.11 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.12 | Sell |
20 | 6.56 | Sell |
50 | 6.58 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.21 | Sell |
20 | 6.39 | Sell |
50 | 6.58 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.11 | Neutral |
20 | 6.49 | Neutral |
50 | 6.54 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.98 | Sell |
20 | 6.17 | Sell |
50 | 6.35 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.93 | Sell |
20 | 6.0 | Sell |
50 | 6.32 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 6.25 |
Resistance L2 | 6.16 |
Resistance L1 | 6.02 |
Pivot Point | 5.93 |
Support L1 | 5.79 |
Support L2 | 5.7 |
Support L3 | 5.56 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.